Oncocyte Announces Oral Presentation of New Data on Its DetermaIO™ Immunotherapy Response Test at the European Society for Medical Oncology Annual MeetingGlobeNewsWire • 09/20/21
Modern Healthcare Recognizes Oncocyte as One of the 2021 Best Places to Work in HealthcareGlobeNewsWire • 09/16/21
Oncocyte to Participate in the 5th Annual Lake Street Capital Markets Best Ideas Growth ConferenceGlobeNewsWire • 09/07/21
Is the Options Market Predicting a Spike in OncoCyte (OCX) Stock?Zacks Investment Research • 08/18/21
Oncocyte Launches First Real-World Evidence (RWE) Registry to Evaluate Biomarker Impact on Early-Stage Lung Cancer Treatment Decisions and OutcomesGlobeNewsWire • 08/17/21
Oncocyte Corporation (OCX) CEO Ronnie Andrews on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/11/21
Oncocyte Reports Second Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 08/10/21
Oncocyte to Report Second Quarter 2021 Financial Results on Tuesday, August 10GlobeNewsWire • 07/27/21
EchelonDx and Oncocyte Announce Collaboration to Create Seamless Informatics Software to Scale Proprietary Clinical Test OfferingsBusiness Wire • 06/15/21
Oncocyte Announces Collaboration with Gruppo Oncologico del Nord Ovest to Evaluate Oncocyte's DetermaIO Test in Colorectal Cancer, the Second Leading Cause of Cancer Mortality GloballyGlobeNewsWire • 06/03/21
OncoCyte Corporation (OCX) CEO Ronnie Andrews on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/18/21
Oncocyte Reports First Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 05/17/21
Will OncoCyte (OCX) Report Negative Q1 Earnings? What You Should KnowZacks Investment Research • 05/04/21
Oncocyte to Present New Data on DetermaIO™ Test as a Predictor of Immunotherapy Response in Renal Cell Cancer at the 2021 ASCO Annual MeetingGlobeNewsWire • 04/28/21
Oncocyte Enters the Rapidly Growing Immune Therapy Monitoring Market with the Closing of the Acquisition of Chronix Biomedical, Inc.GlobeNewsWire • 04/19/21
Oncocyte Hosting Key Opinion Leader Call on Novel Biomarkers in Identifying Appropriate Responders to Immune Checkpoint InhibitorsGlobeNewsWire • 04/14/21
Oncocyte Presents New Data at 2021 American Association for Cancer Research Annual Meeting Demonstrating Potential for Pan-Cancer Utility of DetermaIO™GlobeNewsWire • 04/10/21
Oncocyte to Participate in Fireside Chat at the 20th Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 04/06/21
Best Stocks for 2021: OCX Got Off to a Fast Start But the Best Is Yet to ComeInvestorPlace • 04/01/21